Education
About Us
Working with TipRanks
Follow Us
Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)
:1167
1167 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$1.20 - HK$11.80
Previous CloseN/A
Volume546.60K
Average Volume (3M)9.53M
Market Cap
HK$7.63B
Enterprise ValueHK$2.51B
Total Cash (Recent Filing)HK$1.07B
Total Debt (Recent Filing)HK$143.01M
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Mar 25, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding791,755,070
10 Day Avg. Volume3,970,969
30 Day Avg. Volume9,525,733
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)1.00
Price to Sales (P/S)5.94
P/FCF Ratio-10.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$5.30Price Target Upside-39.50% Downside
Rating ConsensusHold
Number of Analyst Covering0
Jacobio Pharmaceuticals Group Co., Ltd. News
1167 FAQ
What was Jacobio Pharmaceuticals Group Co., Ltd.’s price range in the past 12 months?
Jacobio Pharmaceuticals Group Co., Ltd. lowest stock price was HK$1.20 and its highest was HK$11.80 in the past 12 months.
What is Jacobio Pharmaceuticals Group Co., Ltd.’s market cap?
Jacobio Pharmaceuticals Group Co., Ltd.’s market cap is HK$7.63B.
When is Jacobio Pharmaceuticals Group Co., Ltd.’s upcoming earnings report date?
Jacobio Pharmaceuticals Group Co., Ltd.’s upcoming earnings report date is Mar 25, 2026 which is in 165 days.
How were Jacobio Pharmaceuticals Group Co., Ltd.’s earnings last quarter?
Jacobio Pharmaceuticals Group Co., Ltd. released its earnings results on Aug 29, 2025. The company reported -HK$0.087 earnings per share for the quarter, the consensus estimate of -HK$0.087 by HK$0.
Is Jacobio Pharmaceuticals Group Co., Ltd. overvalued?
According to Wall Street analysts Jacobio Pharmaceuticals Group Co., Ltd.’s price is currently Overvalued.
Does Jacobio Pharmaceuticals Group Co., Ltd. pay dividends?
Jacobio Pharmaceuticals Group Co., Ltd. does not currently pay dividends.
What is Jacobio Pharmaceuticals Group Co., Ltd.’s EPS estimate?
Jacobio Pharmaceuticals Group Co., Ltd.’s EPS estimate is -0.12.
How many shares outstanding does Jacobio Pharmaceuticals Group Co., Ltd. have?
Jacobio Pharmaceuticals Group Co., Ltd. has 791,755,070 shares outstanding.
What happened to Jacobio Pharmaceuticals Group Co., Ltd.’s price movement after its last earnings report?
Jacobio Pharmaceuticals Group Co., Ltd. reported an EPS of -HK$0.087 in its last earnings report, expectations of -HK$0.087. Following the earnings report the stock price went up 9.299%.
Which hedge fund is a major shareholder of Jacobio Pharmaceuticals Group Co., Ltd.?
Currently, no hedge funds are holding shares in HK:1167
Jacobio Pharmaceuticals Group Co., Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
HK$5.30 (-39.50% Downside)
HK$5.30 (-39.50% Downside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
376.34%
12-Months-Change
Fundamentals
Return on Equity
-5.08%
Trailing 12-Months
Asset Growth
0.29%
Trailing 12-Months
Company Description
Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. (1167) is a biopharmaceutical company headquartered in China, focused on the research, development, and commercialization of innovative medicines. The company operates primarily in the oncology sector, developing targeted therapies and immuno-oncology treatments aimed at improving patient outcomes in cancer care. Jacobio's core products include a range of drug candidates that are in various stages of clinical trials, as well as collaborations with other pharmaceutical entities to enhance its research capabilities and market reach.
Technical Analysis
Viva Biotech Holdings
―
TOT BIOPHARM International Co. Ltd.
―
Jiangsu Recbio Technology Co., Ltd. Class H
―
CStone Pharmaceuticals
―
SinoMab Bioscience Ltd.
―
Options Prices
Currently, No data available
---